Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24-month extension study of FTY720 versus mycophenolate mofetil with Neoral and steroids in adult de novo renal transplant recipients
2004-000587-26Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2004
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fingolimod, mycophenolate mofetil and cyclosporine in kidney transplant immunosuppression (3 arms), sponsored by Novartis. Primary endpoint: Primary composite endpoint. Started Nov 2004; status: completed.
02
Drugs
fingolimodmycophenolate mofetilcyclosporine
03
Conditions
kidney transplant immunosuppression
Beyond the preview
Go deeper on 2004-000587-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000587-26.